Brief: Astrazeneca Opens Global Strategic R&D Center In Kendall Square, Massachusetts
BRIEF-Astrazeneca Opens Global Strategic R&D Center In Kendall Square, Massachusetts Oct 5 (Reuters) - AstraZeneca PLC AZN.L:
ASTRAZENECA OPENS NEW GLOBAL STRATEGIC RESEARCH AND DEVELOPMENT CENTER IN KENDALL SQUARE, CAMBRIDGE, MASSACHUSETTS
ASTRAZENECA - INVESTS $1 BILLION TO GROW MASSACHUSETTS WORKFORCE BY OVER 50%
Source text: ID:nBw9VyhGfa
Further company coverage: AZN.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AstraZeneca
See all newsAstraZeneca says FDA approves drug for rare kidney disease in adults
AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial
Early US flu season, current strain may signal risk for younger people; doctors urge shots
AstraZeneca partners with Oracle for AI-driven clinical trials
Factbox: Pharma sector doubles down on AI to slash costs, timelines